Investing Profile

Peter Keen

Angel
Independent Investment Committee member at British Patient Capital (Direct Investments)
Cambridge, Massachusetts
Photo of Peter Keen, Angel

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Angel
$5K - $50K
$25K
4
CompanyStageDateRound SizeTotal Raised
SupaPass
SeedMar 2020$620K
SeedDec 2015$650K
SeedNov 2014$920K
$2.2M
Small Pharma
SeedApr 2017$1M
$1M
£830K
Co-investors: Ken Belotsky (Negev Capital), David Ebsworth
Independent Investment Committee member British Patient Capital (Direct Investments)2021 - Present
Non Executive Director Endomagnetics Limited2017 - Present
Board of Trustees LifeArc (formerly MRC Technology)2013 - 2021
Non Executive Director SpringWorks Therapeutics2017 - 2019
Non Executive Director Biotech Growth Trust PLC1997 - 2017
Non Executive Director Congenica Ltd2014 - 2016
CEO/Executive Director Cambridge Innovation Capital plc2013 - 2016
Senior Independent Director Abcam PLC2005 - 2014
Member of Supervisory Board Kiadis Pharma2012 - 2013
Venture Partner DFJ Esprit LLP2012 - 2013
Non Executive Director Horizon Discovery Ltd2011 - 2013
Non Executive Director Q Chip Ltd2011 - 2013
Chairman Oval Medical Technologies Limited2010 - 2013
Non Executive Director Ark Therapeutics PLC1998 - 2012
Chairman Exosect Limited2010 - 2011
Corporate Development and Finance Director Serentis Ltd2007 - 2010
Partner DFJ Esprit LLP2006 - 2007
Chief Financial Officer Arakis Ltd2004 - 2006
UK Managing Director/Consultant Merlin Biosciences1996 - 2004
University of Hull BSc (Econ) Economics and Accountancy